Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
CAMP4 Therapeutics Corporation (CAMP) had Income from Continuous Operations of $-15.10M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.80M |
|
$-15.10M |
|
-- |
|
$0.80M |
|
$14.45M |
|
$-13.65M |
|
$-1.45M |
|
$-15.10M |
|
$-15.10M |
|
$-15.10M |
|
|
Income from Continuous Operations |
$-15.10M |
$-15.10M |
|
$-15.10M |
|
$-13.65M |
|
$-13.23M |
|
27.27M |
|
27.27M |
|
$-0.55 |
|
$-0.55 |
|
| Balance Sheet Financials | |
$77.71M |
|
$2.90M |
|
$8.69M |
|
$86.39M |
|
$7.90M |
|
$0.05M |
|
$19.82M |
|
$27.73M |
|
$58.67M |
|
$58.67M |
|
$58.67M |
|
46.88M |
|
| Cash Flow Statement Financials | |
$-35.85M |
|
$-0.24M |
|
$47.30M |
|
$65.66M |
|
$76.88M |
|
$11.22M |
|
$2.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.83 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
100.00% |
|
-1717.11% |
|
-1717.11% |
|
-- |
|
-1899.24% |
|
-1899.24% |
|
$-36.09M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-25.74% |
|
-25.74% |
|
-17.48% |
|
-25.72% |
|
$1.25 |
|
$-1.32 |
|
$-1.31 |
|